BEXEL PHARMACEUTICALS INC has a total of 45 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are TECHFIELDS BIOCHEM CO LTD, NEWLINK GENETICS CORP and SMITHKLINE BEECHAM CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | China | 4 | |
#4 | Republic of Korea | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | Canada | 3 | |
#7 | Taiwan | 3 | |
#8 | Australia | 1 | |
#9 | Brazil | 1 | |
#10 | Hungary | 1 | |
#11 | Morocco | 1 | |
#12 | Mexico | 1 | |
#13 | Norway | 1 | |
#14 | New Zealand | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Dey Debendranath | 37 |
#2 | Nag Bishwajit | 36 |
#3 | Nag Abhijeet | 26 |
#4 | Neogi Partha | 25 |
#5 | Agarwal Shiv Kumar | 22 |
#6 | Nag Abjiheet | 10 |
#7 | Pandey Surendra Kumar | 9 |
#8 | Singh Gajendra | 6 |
#9 | Badiger Sangamesh | 6 |
#10 | Chithra Santhanagopalan | 6 |
Publication | Filing date | Title |
---|---|---|
US2008175795A1 | Novel derivatives of amino acids for treatment of obesity and related disorders | |
US2008200521A1 | Novel hydroxamic acid containing amino acid derivatives | |
US2006247285A1 | Heterocyclic diphenyl ethers | |
CN101160296A | 5- [4- (4- (2 -amino- 2 -methoxycarbonylethyl) phenoxy) benzilidene] thiazolidin-2, 4-dion e derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma | |
US2007004776A1 | Hydroxamic acid-containing amino acid derivatives | |
US2007004725A1 | Derivatives of amino acids for treatment of obesity and related disorders | |
US2005288341A1 | Diphenyl ether derivatives | |
US2004259891A1 | Pyrimidone derivatives | |
CN1758907A | Amino acid phenoxy ethers | |
US2005075293A1 | Dipeptide phenyl ethers | |
US6794401B2 | Amino acid phenoxy ethers |